Download interactions: TXT MITAB-2.5
| Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
|---|---|---|---|---|---|---|
|
TIMP1
Metalloproteinase inhibitor 1 |
2 |
20 |
Small-scale |
0.838 | High |
|
|
TIMP4
Metalloproteinase inhibitor 4 |
1 |
20 |
Small-scale |
0.735 | High |
|
|
TIMP2
Metalloproteinase inhibitor 2 |
1 |
20 |
Small-scale |
0.647 | High |
|
|
PGCB
Brevican core protein |
1 |
15 |
Small-scale |
0.647 | High |
|
|
IL8
Interleukin-8 |
2 |
20 |
Small-scale |
0.602 | High |
|
|
CXCL5
C-X-C motif chemokine 5 |
2 |
20 |
Small-scale |
0.602 | High |
|
|
ITA2
Integrin alpha-2 |
2 |
11 |
Small-scale |
0.543 | High |
|
|
FOS
Protein c-Fos |
2 |
8 |
Small-scale |
0.533 | High |
|
|
CXCL7
Platelet basic protein |
1 |
20 |
Small-scale |
0.501 | High |
|
|
CO1A2
Collagen alpha-2(I) chain |
1 |
17 |
Small-scale |
0.501 | High |
|
|
CXCL2
C-X-C motif chemokine 2 |
1 |
20 |
Small-scale |
0.501 | High |
|
|
CXCL6
C-X-C motif chemokine 6 |
1 |
20 |
Small-scale |
0.501 | High |
|
|
SOX8
Transcription factor SOX-8 |
1 |
1 |
High-throughput |
0.494 | High |
|
|
NEK4
Serine/threonine-protein kinase Nek4 |
1 |
1 |
High-throughput |
0.489 | High |
|
|
GCR
Glucocorticoid receptor |
1 |
3 |
Small-scale |
0.479 | High |
|
|
FOSL1
Fos-related antigen 1 |
1 |
6 |
Small-scale |
0.437 | High |
|
|
CEBPB
CCAAT/enhancer-binding protein beta |
1 |
1 |
Small-scale |
0.437 | High |
|
|
ATF3
Cyclic AMP-dependent transcription factor ATF-3 |
1 |
9 |
Small-scale |
0.437 | High |
|
|
CSK22
Casein kinase II subunit alpha' |
1 |
2 |
High-throughput |
0.437 | High |
|
|
CSK21
Casein kinase II subunit alpha |
1 |
2 |
High-throughput |
0.437 | High |
|
|
CSK23
Casein kinase II subunit alpha 3 |
1 |
2 |
High-throughput |
0.437 | High |
|
|
BASI
Basigin |
1 |
0 |
Small-scale |
0.249 | Low |
|
|
TRIP6
Thyroid receptor-interacting protein 6 |
1 |
0 |
Small-scale |
0.249 | Low |
|
|
CGAS
Cyclic GMP-AMP synthase |
1 |
0 |
High-throughput |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024
